Minor Bladder Procedures without CC/MCC DRG Reimbursement

DRG 664 describes hospital admissions for minor bladder procedures performed without a Complication or Comorbidity or Major Complication or Comorbidity, encompassing low-complexity endoscopic and minor surgical interventions. It matters for inpatient reimbursement because it standardizes payment for lower-resource urologic cases and influences hospital billing, length-of-stay expectations, and resource allocation under Medicare.

DRG 664 Overview

DRG 664 covers admissions for minor bladder procedures performed without a Complication or Comorbidity and without a Major Complication or Comorbidity. Typical cases include diagnostic and limited therapeutic endoscopic bladder interventions where no significant additional diagnoses increase complexity. This Diagnosis-Related Group is important for Medicare payment because it groups lower-resource urologic admissions into a single inpatient reimbursement category, affecting hospital case-mix and revenue for routine bladder procedures.

Acute procedural optimization studies: trials that evaluate methods to reduce intraoperative complications and immediate postoperative issues for minor bladder procedures (such as transurethral resections of small lesions, cystoscopic interventions, or ureteral stent placements). These studies enroll short-stay adult patients undergoing minor endoscopic bladder procedures and focus on anesthesia approaches, bleeding control techniques, and perioperative antibiotic strategies to shorten operative time and reduce same-stay complications. Results are relevant to providers and payers because fewer intraoperative complications and shorter procedure times can lower resource utilization, reduce length of stay, and decrease readmission risk within this DRG.
Comparative effectiveness research on procedural vs conservative management for small bladder lesions or symptomatic lower urinary tract pathology: randomized or pragmatic trials comparing minimally invasive office-based or outpatient endoscopic interventions to watchful waiting, medical therapy, or delayed intervention in predominantly older adults with comorbidities. These studies investigate symptom relief, need for repeat procedures, and health-care utilization over months to a year, addressing which initial strategy provides the best balance of clinical benefit and cost for the typical low-acuity DRG 664 population. Findings inform clinical pathways and payer coverage decisions by identifying which approaches reduce downstream procedures, complications, and total episode costs.
Post-discharge outcomes and care coordination studies: observational cohort or quality-improvement trials that track postoperative functional outcomes, infection rates, urinary retention, and unplanned ED visits or readmissions in patients discharged after minor bladder procedures. These studies often target transitional care interventions (e.g., standardized discharge instructions, early follow-up calls, or nurse-led symptom monitoring) in older adults and medically complex patients who are common in this DRG. Demonstrating reductions in post-discharge complications and readmissions is important for hospitals and payers aiming to optimize episode-based payments and improve value for this relatively low-severity, high-volume procedure group.

Acute procedural optimization studies: trials that evaluate methods to reduce intraoperative complications and immediate postoperative issues for minor bladder procedures (such as transurethral resections of small lesions, cystoscopic interventions, or ureteral stent placements). These studies enroll short-stay adult patients undergoing minor endoscopic bladder procedures and focus on anesthesia approaches, bleeding control techniques, and perioperative antibiotic strategies to shorten operative time and reduce same-stay complications. Results are relevant to providers and payers because fewer intraoperative complications and shorter procedure times can lower resource utilization, reduce length of stay, and decrease readmission risk within this DRG.
Comparative effectiveness research on procedural vs conservative management for small bladder lesions or symptomatic lower urinary tract pathology: randomized or pragmatic trials comparing minimally invasive office-based or outpatient endoscopic interventions to watchful waiting, medical therapy, or delayed intervention in predominantly older adults with comorbidities. These studies investigate symptom relief, need for repeat procedures, and health-care utilization over months to a year, addressing which initial strategy provides the best balance of clinical benefit and cost for the typical low-acuity DRG 664 population. Findings inform clinical pathways and payer coverage decisions by identifying which approaches reduce downstream procedures, complications, and total episode costs.
Post-discharge outcomes and care coordination studies: observational cohort or quality-improvement trials that track postoperative functional outcomes, infection rates, urinary retention, and unplanned ED visits or readmissions in patients discharged after minor bladder procedures. These studies often target transitional care interventions (e.g., standardized discharge instructions, early follow-up calls, or nurse-led symptom monitoring) in older adults and medically complex patients who are common in this DRG. Demonstrating reductions in post-discharge complications and readmissions is important for hospitals and payers aiming to optimize episode-based payments and improve value for this relatively low-severity, high-volume procedure group.

OpenPayer

Summary & Overview

Minor Bladder Procedures without CC/MCC: Inpatient Reimbursement Overview

DRG 664 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes